Works (10)

Updated: July 9th, 2023 21:16

2020 journal article

Feasibility study evaluating arrhythmogenesis and cardiac damage after heart-base irradiation in mice: A brief communication

VETERINARY MEDICINE AND SCIENCE, 6(4), 1009–1016.

By: J. Elliott n, K. Linder n & M. Nolan n

author keywords: animal models; arrhythmia; radiation; radiobiology; radiotherapy
MeSH headings : Animals; Arrhythmias, Cardiac / etiology; Disease Models, Animal; Feasibility Studies; Female; Heart / radiation effects; Mice; Mice, Inbred C57BL; Myocardium / pathology; Pilot Projects
TL;DR: While this study did not demonstrate significant arrhythmogenesis, certain modifications of the experimental mouse irradiation procedures are discussed which may enable more translationally relevant modelling of the canine cardiac response to SBRT‐like irradiation. (via Semantic Scholar)
Source: Web Of Science
Added: June 29, 2020

2020 journal article

Histiocytic sarcoma in miniature schnauzers: 30 cases

JOURNAL OF SMALL ANIMAL PRACTICE, 61(6), 338–345.

By: K. Purzycka*, L. Peters*, J. Elliott n, C. Lamb*, S. Priestnall*, A. Hardas, C. Johnston*, I. Rodriguez-Piza*

MeSH headings : Animals; Dog Diseases; Dogs; Histiocytic Sarcoma / veterinary; Lomustine; Retrospective Studies
TL;DR: Histiocytic sarcoma should be considered as a differential diagnosis for miniature schnauzers with pulmonary masses and responses to treatment were common, they were usually short-lived because of the aggressive nature of the disease. (via Semantic Scholar)
Source: Web Of Science
Added: May 8, 2020

2020 journal article

Primary tonsillar histiocytic sarcoma in two dogs

VETERINARY RECORD CASE REPORTS, 8(3).

By: C. Llanos*, A. Lara* & J. Elliott n

author keywords: histiocytic sarcoma; canine; CCNU; tonsillar; cancer
TL;DR: An eight-year-old, female-spayed Golden Retriever presented with a tonsillar mass, which was diagnosed as histiocytic sarcoma (HS), following tonsillectomy remains alive with no evidence of tumour recurrence 18 months after diagnosis. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: October 12, 2020

2020 journal article

Response and outcome following radiation therapy of macroscopic canine plasma cell tumours

VETERINARY AND COMPARATIVE ONCOLOGY, 18(4), 718–726.

author keywords: cancer; canine; radiation oncology; plasma cell; tumor
MeSH headings : Animals; Antineoplastic Agents / therapeutic use; Combined Modality Therapy / veterinary; Dog Diseases / drug therapy; Dog Diseases / mortality; Dog Diseases / radiotherapy; Dogs; Female; Male; Plasmacytoma / drug therapy; Plasmacytoma / mortality; Plasmacytoma / radiotherapy; Plasmacytoma / veterinary; Progression-Free Survival; Radiotherapy Dosage / veterinary; Retrospective Studies; Survival Rate; Treatment Outcome
TL;DR: RT is a useful therapeutic modality for PCTs and tumour responses are often complete and durable, with protracted survivals, and palliative-intent RT was associated with inferior MST as compared with definitive- intent RT. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Sources: Web Of Science, NC State University Libraries
Added: June 1, 2020

2019 journal article

A Retrospective Study of Multi-agent Chemotherapy including either Cyclophosphamide or Lomustine as Initial Therapy for Canine High-grade T-cell Lymphoma (2011-2017)

AUSTRALIAN VETERINARY JOURNAL, 97(9), 308–315.

By: J. Elliott* & S. Baines*

author keywords: Canine; lymphoma; T-cell; chemotherapy; lomustine; dog
MeSH headings : Animals; Antibiotics, Antineoplastic / therapeutic use; Antineoplastic Agents, Alkylating / pharmacology; Antineoplastic Agents, Hormonal / therapeutic use; Antineoplastic Agents, Phytogenic / therapeutic use; Antineoplastic Combined Chemotherapy Protocols / therapeutic use; Cyclophosphamide / pharmacology; Disease-Free Survival; Dog Diseases / drug therapy; Dogs; Epirubicin / therapeutic use; Female; Lomustine / pharmacology; Lymphoma, T-Cell / drug therapy; Lymphoma, T-Cell / veterinary; Male; Neutropenia / chemically induced; Prednisolone / therapeutic use; Retrospective Studies; United Kingdom; Vincristine / therapeutic use
TL;DR: Overall survival was improved for patients receiving LEOP compared to those receiving CEOP followed by lomustine-based rescue therapy, and progression-free survival and overall survival were significantly higher in patients receiving Leopoldine compared to CEOP. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: August 12, 2019

2019 journal article

Evaluation of a multi-agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non-Hodgkin high-grade lymphomas: a single centre's experience

VETERINARY AND COMPARATIVE ONCOLOGY, 17(2), 165–173.

By: K. Smallwood*, J. Tanis*, I. Grant*, L. Blackwood*, D. Killick*, I. Amores-Fuster*, J. Elliott*, A. Mas* ...

author keywords: actinomycin-D; canine lymphoma; chemotherapy; DMAC; dog; melphalan; rescue; resistant lymphoma
MeSH headings : Animals; Antibiotics, Antineoplastic / pharmacology; Antimetabolites, Antineoplastic / pharmacology; Antineoplastic Agents / pharmacology; Antineoplastic Agents, Alkylating / pharmacology; Antineoplastic Agents, Hormonal / pharmacology; Antineoplastic Combined Chemotherapy Protocols / pharmacology; Cohort Studies; Cytarabine / pharmacology; Dactinomycin / pharmacology; Databases, Factual; Dexamethasone / pharmacology; Dog Diseases / drug therapy; Dogs; Female; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin / drug therapy; Lymphoma, Non-Hodgkin / veterinary; Male; Melphalan / pharmacology; Neoplasm Recurrence, Local / drug therapy; Neutropenia / veterinary; Remission Induction; Schools, Veterinary; Thrombocytopenia / veterinary; Treatment Outcome; United Kingdom
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: May 13, 2019

2019 journal article

Managing cancer pain in dogs and cats

IN PRACTICE, 41(8), 361–367.

By: J. Elliott* & B. Alderson

TL;DR: The types of pain commonly associated with cancer and the analgesics and other treatments that can be used to manage this pain are reviewed. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: November 4, 2019

2019 journal article

Response and outcome following toceranib phosphate treatment for stage four anal sac apocrine gland adenocarcinoma in dogs: 15 cases (2013-2017)

JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 254(8), 960–966.

By: J. Elliott*

MeSH headings : Adenocarcinoma / veterinary; Anal Sacs; Animals; Apocrine Glands; Dog Diseases; Dogs; Indoles; Pyrroles; Quality of Life; Retrospective Studies; Treatment Outcome
TL;DR: Results of the present study indicated that dogs with stage 4 ASAGA treated with toceranib had improved outcomes, compared with outcomes previously reported for dogs with ASAGA that had received non-tyrosine kinase inhibitor treatments. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: April 22, 2019

2019 personal communication

Should we be euthanasing cancer patients?

Elliott, J., & Alderson, B. (2019, November 2).

By: J. Elliott n & B. Alderson*

MeSH headings : Animals; Euthanasia, Animal; Neoplasms / complications; Neoplasms / veterinary; Pain Management / veterinary
TL;DR: It was great to read that the article the authors recently published ‘Managing cancer pain in cats and dogs’, in October’s In Practice , is being read, but they worry, given Peter Clark's comment, that the articles message has been taken out of context. (via Semantic Scholar)
Source: Web Of Science
Added: December 30, 2019

2018 journal article

Lomustine chemotherapy for the treatment of presumptive haemophagocytic histiocytic sarcoma in Flat-coated Retrievers

AUSTRALIAN VETERINARY JOURNAL, 96(12), 502–507.

By: J. Elliott*

author keywords: dogs; haemophagocytic histiocytic sarcoma; lomustine
MeSH headings : Animals; Antineoplastic Agents, Alkylating / therapeutic use; Dog Diseases / drug therapy; Dog Diseases / pathology; Dogs; Histiocytic Sarcoma / drug therapy; Histiocytic Sarcoma / pathology; Histiocytic Sarcoma / veterinary; Lomustine / therapeutic use; Lymphohistiocytosis, Hemophagocytic / veterinary; Retrospective Studies; Spleen / pathology; Survival; Treatment Failure
TL;DR: HPHS affecting FCRs appears to have a uniformly poor outcome and is rapidly fatal, and lomustine chemotherapy was unsuccessful in significantly improving outcome in this cohort of patients. (via Semantic Scholar)
UN Sustainable Development Goal Categories
Source: Web Of Science
Added: December 10, 2018

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.